Synergistic interaction between sorafenib and gemcitabine in EGFR-TKI-sensitive and EGFR-TKI-resistant human lung cancer cell lines

Jing Li(Anhui Medical University), Ying Zhang(Shantou University)
Oncology Letters
November 7, 2012
Cited by 17


Related Papers